Nanomedicine: How nanomaterials are transforming drug delivery, bio-imaging, and diagnosis

Abstract

This review article comprehensively examines the role of nanotechnology in advancing medical science, with a focus on its applications in drug delivery, diagnostics, and tissue engineering. We explore the classification of nanomaterials based on dimensionality, composition, and dispersion, and discuss their critical role in revolutionizing medicine. Nanomaterials such as liposomes, protein-based nanoparticles, and dendrimers are highlighted for their ability to enhance drug delivery systems, improving targeting, bioavailability, and reducing side effects. We investigate theranostics, where nanoparticles integrate diagnostic imaging and treatment capabilities in a single platform, enabling more effective cancer therapies through targeted drug delivery. The article also covers advancements in tissue engineering, where nanomaterial-based scaffolds are used to regenerate damaged tissues and organs. We present novel developments in creating bioinspired scaffolds using chitosan, cellulose, and graphene oxide, which improve cell adhesion and enhance mechanical properties for tissue regeneration. The review also discusses the nanoparticles’ potential in bioimaging tools such as MRI, PET, and fluorescent imaging. We highlight cutting-edge developments in nanoparticle-based contrast agents that improve imaging accuracy and enable real-time monitoring of therapeutic interventions. Our review stands out by integrating recent advancements in the multifunctional use of nanomaterials for personalized medicine. We address the challenges of toxicity, regulatory concerns, and the future potential of nanotechnology in clinical translation, positioning this work as a significant contribution to the field of nanomedicine. Nanomedicine is an emerging field that harnesses the unique properties of nanomaterials to revolutionize healthcare, offering significant advances in diagnostics, targeted drug delivery, therapeutic interventions, and tissue engineering. This review comprehensively examines the various categories of nanomaterials, including metal-based (e.g., gold and silver), carbon-based (e.g., graphene and carbon nanotubes), organic (e.g., dendrimers and liposomes), and hybrid materials, highlighting their potential applications in drug delivery, bioimaging, and theranostics. Nanomaterials are utilized for their ability to improve drug bioavailability, target specific tissues, and enable precise control over drug release, making them highly effective in treating diseases like cancer and neurological disorders. The review explores the mechanisms and clinical applications of key imaging technologies such as Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), fluorescence, and surface-enhanced Raman scattering (SERS), where nanomaterials significantly enhance sensitivity, resolution, and tissue penetration. Additionally, the role of aggregation-induced emission (AIE) in fluorescence imaging and the promise of nanoparticle-based theranostic platforms—integrating both diagnostic and therapeutic functions—are discussed in depth. These multifunctional nanoparticles have the potential to revolutionize personalized medicine by offering precise disease monitoring and treatment simultaneously. Further, the review delves into the clinical progress and regulatory aspects of nanomedicine, noting recent advancements in clinical trials and approved therapies, including mRNA-based vaccines and targeted nanomedicine therapies for cancer. The development of nanoparticle-based scaffolds for tissue regeneration and their integration into clinical practice are also highlighted, alongside challenges in biocompatibility, toxicity, and scalability. The discussion includes insights into patents, ongoing clinical studies, and the road ahead for overcoming current limitations in nanomedicine. This review provides a holistic view of the state of nanomedicine, offering a comprehensive understanding of its current and future impact on healthcare, therapeutic efficacy, and clinical translation.